Head & Associate Vice President-Business Development

Portfolio & Strategy, Kashiv BioSciences LLC

 

Global General Counsel

Dr. Reddy's Laboratories

 

Sr Regional Manager and Head (IPFC & TISC)

National Research Development Corporation (DSIR Enterprise, Ministry of S&T, Govt. of India)

 

SHAREHOLDER

Maynard's New York

 

Chris Harnett, a Shareholder in Maynard's New York Office, focuses his practice on the litigation of intellectual property matters. Over the past three decades, Chris has litigated cases in more than 35 jurisdictions around the country, prevailing for clients at the pleadings stage, during claim construction, in securing and opposing preliminary injunctive relief, on summary judgment, at bench and jury trials, and after appellate review. Those cases involved a wide range of technologies, including pharmaceuticals, biotechnology, medical devices, computer systems, and consumer products.

Chris works closely with clients to develop integrated legal and business- focused strategies that best serve their needs, relying on his strong background in science and his litigation expertise. A registered patent attorney, Chris also represents clients in IPR proceedings and assists clients in managing their patent portfolios and in evaluating the competitive patent landscape in anticipation of potential litigation.

After graduating from the Georgetown University Law Center in 1990, Chris began his career at the preeminent intellectual property law firm, Fish & Neave, where he was a Partner for many years.

Christopher's Experience Notable Cases and Successes

• Represented Takeda against Torrent Pharmaceuticals and Indoco Remedies, defeating ANDA challenges to Takeda’s patents protecting its Alogliptin product (a DPP-IV inhibitor used to treat Type-II diabetes). (D.NJ).
• Represented Celgene/BMS securing favorable IPR decisions directed to patents covering their breast cancer drug, Abraxane. (PTAB).
• Represented Medac against Antares, prevailing in preliminary injunction, summary judgment and appellate proceedings directed to Medac’s methotrexate injector product used to treat rheumatoid arthritis. (D.Del.; CAFC.).
• Represented Praxair against ATMI securing jury trial, summary judgment and appellate victories concerning delivery systems for highly toxic gasses used to manufacture semiconductors. (SDNY; D.Del., CAFC).
• Represented Fisher Controls prevailing in a jury trial and appeal against Neles-Jamesbury in a case concerning noise attenuating industrial valves. (D.Mass.; CAFC).
• Represented Fisher-Rosemount against Control Systems, Inc. securing summary judgment on several grounds and defeating a nine-figure damages claim in a case concerning computerized industrial control systems. (S.D.Tx.).
• Represented a Multinational Electronics Company against Imperium IP Holdings (Cayman) successfully defending against three patents and a eight-figure damages claim concerning image sensors and camera modules. (E.D. Tx.).
• Represented Massachusetts Eye and Ear Infirmary against QLT Phototherapeutics securing a $125M jury verdict concerning a surgical method and photodynamic drug used for treatment of macular degeneration. (D.Mass.; 1st Cir.)
• Represented Senju Pharmaceutical Co. against Akorn and Apotex in favorably settled ANDA cases directed to the ophthalmological drug, Istalol. (SDNY).
• Represented Schering Plough in an ANDA case against Barr Labs, successfully defending Schering Plough’s patent covering temozolomide, a drug used for the treatment of gliomas. (D.Del.; CAFC.).
• Represented Astra-Zeneca securing a preliminary injunction against Apotex directed to Astra Zeneca’s Pulmicort Respules product, which is used as an asthma treatment for children. (D.NJ).
• Represented Agilent successfully defending against an infringement charge brought by Genetic Techs. Ltd. concerning processes involving the use of non-coding regions of DNA molecules. (N.D. Cal.).
• Represented Forest Labs and ONY Inc. successfully defending against patent claims maintained by Tokyo Tanabe concerning Infasurf, a drug used to treat Respiratory Distress Syndrome in premature infants. (NDNY; CAFC).
• Represented Feit Electric Company, Inc. in a favorably settled case involving Blackbird Tech Inc’s assertion of patent claims directed to lighting technology. (D.Del.).
• Represented Becton Dickinson in an arbitration against Critikon successfully asserting patents directed to IV catheter manufacture. (AAA).
• Represented Tyco in a favorable mid-trial settlement of Surgical Dynamics’s assertion of patents directed to spinal implant technology. (W.D. Tenn.).
• Represented Genzyme favorably settling a case directed to sodium hyaluronate injections for treatment of osteoarthritis prior to appeal, after obtaining a preliminary injunction. (D.Mass.).
• Represented a Multinational Technology Company against Vederi securing summary judgment of non-infringement of four patents directed to geo-location technology. (C.D. Cal.)
• Represented Tessera securing a favorable mid-trial settlement against semiconductor manufacturers concerning patented chip miniaturization technology. (N.D. Cal.).

Christopher's Awards

• Chambers USA: Leader in the area of Intellectual Property: Patent (2018-present)
• The Legal 500 US: Intellectual Property — Patent Litigation
• IAM Patent 1000: The World's Leading Patent Practitioners (2014- 2016)
• The Best Lawyers in America for Litigation: Intellectual Property and Litigation: Patent (2009-present)

Who's Who Legal (2016) New York Super Lawyers (2006-2016) Lawdragon 500 "New Stars, New Worlds"

 

Lawyer

Green, Griffith & Associates LLP

 

Founding Partner

Pergament & Cepeda LLP

Mr. Pergament litigates patent infringement actions and drafts patent opinions for a variety of pharmaceutical clients from India, China, Russia, and North America. Mr. Pergament primary expertise is in positioning pharmaceutical assets versus patent portfolios, both offensively and defensively, by any means available under the law, including patent litigation, patent strategy considerations, and patent procurement. Mr. Pergament has a broad legal, business and technical expertise in pharmaceutical and cosmetic industry. At present, Mr. Pergament’s practice is focused mainly on pharmaceutical patent litigation and establishing litigation positions for generic pharmaceutical companies, and on counseling brand side clients in pharmaceutical and chemical industries with respect to life cycle management and other strategic issues, including portfolio management. Mr. Pergament was a scientist, an attorney, and an executive with several major pharmaceutical companies, and he has hand-on understanding of legal, business, and technical issues facing a broad range of pharmaceutical products, including NCEs, specialty, generics, formulations, and pharmaceutical solids.
Admissions: New York, 2000, New Jersey, 2001; U.S. Court of Appeals for the Federal Circuit; registered to practice before U.S. Patent and Trademark Office (1997).
Education: University of Odessa, former USSR (B.Sc., Chemistry/Organic Chemistry, 1985); Case Western Reserve University (M.Sc., Chemistry/Organic Chemistry, 1993); Rutgers School of Law, cum laude, Order of the Coif (J.D., 1999).
Practice Areas: Pharmaceutical Patent Litigation, Pharmaceutical Patent Law, and Counseling

Partner

McAndrews, Held & Malloy Ltd

Alex is a partner at the firm of McAndrews, Held & Malloy in Chicago, Illinois, where he leads the Hatch-Waxman and Biosimilar litigation practice. Alex’s practice includes patent and trademark litigation and client counseling, with a focus on ANDA and Biosimilar litigation and counselling. Alex is an Adjunct Professor at UIC Law School in Chicago and has been teaching intellectual property related law classes for over 25 years. Alex is fluent in Spanish represents numerous Spanish-speaking clients.

McANDREWS HELD & MALLOY LTD
500 WEST MADISON STREET 34TH FLOOR
CHICAGO ILLINOIS 60661
(T) 312 775 8103
amenchaca@mcandrews-ip.com
www.mcandrews-ip.com

Head & Patent Counsel Intellectual Property Management

Unichem labs

 

United States Intellectual Property Counselor for South Asia

U.S. Embassy – New Delhi, India

 

Partner and Head IP of Patent – Design - Copyright Department

United Trademark & Patent Services

 

Director, Head - IPR department

Neuland Laboratories Limited

 

Sr. Director (Head) – IP

Fresenius Kabi

 

Vice President & Head – Global Portfolio

BD & IP, Granules India Limited

 

General manager - Intellectual Property

Godavari Biorefineries Limited

 

Partner, Co-Chair Pharmaceutical Practice, Co-Chair Litigation Practice

Cantor Colburn LLP

Steven Coyle is a Partner and co-chairs the firm's Litigation Practice. He is a trial lawyer with more than 25 years' experience litigating and trying complex disputed matters, and specializes in patent and all varieties of intellectual property litigation. Steven’s areas of focus include ANDA and Hatch-Waxman litigation, where he has represented the rights of generic drug manufacturers and helped them to bring products to market. Steven also counsels clients in FDA matters and is the Chair of Cantor Colburn’s Pharmaceutical Litigation Practice. Steven represents clients as both plaintiffs and defendants in a variety of other patent matters, including software, cybersecurity, fiber optics, lighting, circuit boards, robotics, telecommunications, piping systems, and consumer goods. Steven has substantial experience litigating trademark, copyright, and trade secret matters as well. He has litigated in courts throughout the country, and he has represented clients in alternative dispute resolution forums such as arbitrations and mediations. Steven has also handled multiple appeals, including before the Federal Circuit. In all of his cases, Steven strives to develop and follow a pragmatic strategy that advances not only his clients’ short term litigation goals but also their long term business needs.

Partner

Kratz & Barry LLP

Timothy is a veteran complex trial lawyer, with over 32 years of first-chair courtroom experience. He leads or has led litigation teams in numerous large, complex matters, including cases in the fields of patents and other forms of intellectual property, technology licenses and development, trade and competition, healthcare, securities, professional malpractice and all aspects of business litigation. For the past 18 years, he has built and led teams focused on Hatch-Waxman litigation, serving as lead counsel in all phases of numerous ANDA cases for leading generic pharmaceutical companies. He has significant experience in this field, including serving as lead counsel on more than 100 ANDA applications with Paragraph IV challenges.

Timothy is a recognized international speaker on topical issues pertinent to the life sciences industry and patent litigation, having presented at industry conferences throughout the United States, and in South Korea and on numerous occasions in India. He has been tendered and qualified as an expert in an international litigation matter in the field of U.S. patent litigation procedures. He was also his prior firm’s chair of the life sciences industry team, serving in this firm management position for more than two years. As such, he has coordinated multi-disciplinary and multi-office teams of lawyers serving the life sciences industry.

Timothy has a depth of experience in the management of high stakes, high profile commercial litigation. He has tried many cases to verdict in a variety of jurisdictions and argued several appeals before federal and state appellate courts and in fact has been selected on multiple occasions from joint-defense group counsel to argue an appeal on behalf of multiple leading companies in the field. He has also taught trial advocacy skills to both law students and lawyers in several states. He has been a member of the Georgia bar since 1989.

Speaker Details